ArticleAntimicrobial agents and chemotherapy2005
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.
Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Increasing Antimicrobial Resistance Profile Diversity of Colonizing Group BAnnals of laboratory medicine · 2026Article
- Genetic Determinants and Clonal Composition of Levofloxacin-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Genetic Mechanisms of Antimicrobial Non-Susceptibility to Novel Fluoroquinolone Delafloxacin Among Bulgarian Clinical Isolates ofCurrent issues in molecular biology · 2025Article
- The landscape of antimicrobial resistance in the neonatal and multi-host pathogen group BFrontiers in microbiology · 2022Article
- Bacterial and Host Determinants of Group B Streptococcal Infection of the Neonate and Infant.Frontiers in microbiology · 2022Review
- Emergence of Invasive Serotype Ib Sequence Type 10 Group B Streptococcus Disease in Chinese Infants Is Driven by a Tetracycline-Sensitive Clone.Frontiers in cellular and infection microbiology · 2021Article
- Group BMicrobiology spectrum · 2019Review
- Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.Antimicrobial agents and chemotherapy · 2016Article
- Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing.Epidemiology and infection · 2016Article
- Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.Antimicrobial agents and chemotherapy · 2015Article
- Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis.Frontiers in microbiology · 2014Article
- High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.Antimicrobial agents and chemotherapy · 2013Article
- Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012Article
- Molecular characterization of adult-colonizing Streptococcus agalactiae from an area-based surveillance study in Romania.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012Article
- Detection of Group B Streptococcus in Brazilian pregnant women and antimicrobial susceptibility patterns.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2010Article
- Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.Antimicrobial agents and chemotherapy · 2009Article
- Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.Antimicrobial agents and chemotherapy · 2008Article
- Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.Antimicrobial agents and chemotherapy · 2008Article
- Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.Antimicrobial agents and chemotherapy · 2008Article
- Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.Emerging infectious diseases · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Quinolone-resistant Streptococcus agalactiae bacteria were recovered from single-patient isolates and found to contain mutations in the gyrase and topoisomerase IV genes. Pulsed-field gel electrophoresis demonstrated that four isolates from the same long-term care facility were closely related; in seven cases, quinolone-resistant Haemophilus influenzae and S. agalactiae bacteria were isolated from the same patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.